COVID-19 risk in pregnant women and infants :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Risk of COVID-19 infection in pregnant females and infants

Pregnancy Pregnancy
Pregnancy Pregnancy

A study was carried out for presenting the vital findings on clinical outcomes and health recommendations for pregnant females suffering from coronavirus disease and their infants in order to establish some effective preventive medical care guidelines.

See All

Key take away

For prevention of adverse maternal and fetal outcomes, the SARS-CoV-2 transmission cycle must be interrupted by incorporating individual health guidelines, efficient medical care treatment, and hospital preventive practices.

Background

A study was carried out for presenting the vital findings on clinical outcomes and health recommendations for pregnant females suffering from coronavirus disease and their infants in order to establish some effective preventive medical care guidelines.

Method

In this study, the vertical transmission potential of SARS-CoV-2 pneumonia in pregnant females was reviewed. Important symptoms and deleterious clinical outcomes for the mothers and infants prior to and following childbirth were enumerated. Few practical therapies and preventive health solutions were also recommended.

Result

A high susceptibility in pregnant females to coronavirus disease was noted, particularly in the 3rd  trimester of pregnancy. Sore throat (13.5%), dyspnea (27.6%), fever (87.6%), malaise (9.4%), fatigue (22.4%), diarrhea (3.4%), and cough (52.3%) were the most commonly noted symptoms in 22–40-year-old patients having coronavirus disease.

The coronavirus disease elicited a rise in preterm labor and cesarean delivery without triggering serious neonatal asphyxia and intrauterine infection. In spite of an elevated risk of vertical transmission phenomenon, there was no infection in the newborn infants. The reception of antibiotics and antiviral drugs, psychological interventions, oxygenation therapy, and food supplements with health-promoting effects were the most pivotal treatments.

Bi-monthly screening and monitoring the health of mothers and fetuses, not utilizing corticosteroids and broad-spectrum antibiotics, offering a delivery room with negative pressure for emergency cesarean section, and quick isolation of newly born infants without direct breastfeeding were the best proposed medical strategies for the management of coronavirus disease.

Conclusion

Infants suffering from respiratory problems may be born to few females with SARS-CoV-2, who have an immunocompromised immune system. Thus, establishing a risk-appropriate care approach for pregnant females and newborn babies with SARS-COV-2 pneumonia will assist in the prevention of major pregnancy complications.

Source:

Archives of Gynecology and Obstetrics

Article:

Pregnant women and infants against the infection risk of COVID-19: a review of prenatal and postnatal symptoms, clinical diagnosis, adverse maternal and neonatal outcomes, and available treatments

Authors:

Leila Khedmat et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en
Try: